DR. PEGGY CHAN M.D. NPI 1609859875

NPI Details

DR. Peggy Chan, M.D. is a nuclear medicine in Staten Island, NY with 45 years of experience. The provider is a nuclear medicine specialist employs the properties of radioactive atoms and molecules in the diagnosis and treatment of disease and in research. Radiation detection and imaging instrument systems are used to detect disease as it changes the function and metabolism of normal cells, tissues and organs. A wide variety of diseases can be found in this way, usually before the structure of the organ involved by the disease can be seen to be abnormal by any other techniques. Early detection of coronary artery disease (including acute heart attack), early cancer detection and evaluation of the effect of tumor treatment, diagnosis of infection and inflammation anywhere in the body and early detection of blood clot in the lungs are all possible with these techniques. Unique forms of radioactive molecules can attack and kill cancer cells (e.g., lymphoma, thyroid cancer) or can relieve the severe pain of cancer that has spread to bone DR. Peggy Chan, M.D. NPI is 1609859875. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

360 BARD AVE
STATEN ISLAND, NY
ZIP 10310-666
Phone: (718) 876-2000
Fax: (718) 876-2006

The NPI 1609859875 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Nuclear medicine studies of heart muscle at rest and with stress and spect (HCPCS:78452)
• Nuclear medicine study of bone and/or joint whole body (HCPCS:78306)
• Injection, regadenoson, 0.1 mg (HCPCS:J2785)
• Injection, dipyridamole, per 10 mg (HCPCS:J1245)
• Technetium tc-99m tetrofosmin, diagnostic, per study dose (HCPCS:A9502)
• Fluciclovine f-18, diagnostic, 1 millicurie (HCPCS:A9588)
• Nuclear medicine study of brain with metabolic evaluation (HCPCS:78608)
• Technetium tc-99m sestamibi, diagnostic, per study dose (HCPCS:A9500)
• Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician (HCPCS:93015)
• Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries (HCPCS:A9503)
• Nuclear medicine study, 1 area with spect (HCPCS:78803)
• Nuclear medicine study, 1 area with spect (HCPCS:78803)
• Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries (HCPCS:A9561)
• Nuclear medicine study of bone and/or joint whole body (HCPCS:78306)
• Nuclear medicine study of liver and bile duct system with use of drugs (HCPCS:78227)
• Nuclear medicine study of stomach to assess emptying (HCPCS:78264)
• Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries (HCPCS:A9537)
• Nuclear medicine studies of heart muscle at rest and with stress and spect (HCPCS:78452)
• Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries (HCPCS:A9584)
• Injection, furosemide, up to 20 mg (HCPCS:J1940)
• Injection, sincalide, 5 micrograms (HCPCS:J2805)
• Nuclear medicine study of liver and bile duct system (HCPCS:78226)
• Nuclear medicine study of stomach to assess emptying (HCPCS:78264)
• Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries (HCPCS:A9541)
• Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified (HCPCS:A9597)
• Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries (HCPCS:A9562)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)

The enumeration date for this NPI number is 11/22/2005 and was last updated on 3/4/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.